Exact Mass: 368.1999
Exact Mass Matches: 368.1999
Found 94 metabolites which its exact mass value is equals to given mass value 368.1999,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LysoPA(a-13:0/0:0)
{2-hydroxy-3-[(10-methyldodecanoyl)oxy]propoxy}phosphonic acid
LysoPA(a-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(a-13:0/0:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(i-13:0/0:0)
{2-hydroxy-3-[(11-methyldodecanoyl)oxy]propoxy}phosphonic acid
LysoPA(i-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-13:0/0:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
(2-((3,5-Di-t-butyl-4-hydroxyphenyl)thio)-1-methylpropoxy)acetic acid
2-({3-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulphanyl]butan-2-yl}oxy)acetic acid
(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine
Acridin-9-yl-(4-(4-methylpiperazin-1-yl)-phenyl)amine
phthalic acid mono-[2-methyl-5-(2-methyl-3-methylene-[2]norbornyl)-pent-2-enyl ester]|Phthalsaeure-mono-[2-methyl-5-(2-methyl-3-methylen-[2]norbornyl)-pent-2-enylester]
phthalic acid mono-[2-methyl-5-(2-methyl-3-methylene-[2]norbornyl)-pent-2-enyl ester]|Phthalsaeure-mono-[2-methyl-5-(2-methyl-3-methylen-[2]norbornyl)-pent-2-enylester]
2-(4-Methoxyphenyl)-5,7-dimethoxy-6-(3-methyl-2-butenyl)-3,4-dihydro-2H-1-benzopyran
2-(4-Methoxyphenyl)-5,7-dimethoxy-6-(3-methyl-2-butenyl)-3,4-dihydro-2H-1-benzopyran
(6E)-1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6-octen-1-one|1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6(E)-octen-1-one
(6E)-1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6-octen-1-one|1-(2,4-dihydroxyphenyl)-3,7-dimethyl-3-vinyl-8-(4-methyl-2-furyl)-6(E)-octen-1-one
(4E,7E)-1-(2,4-dihydroxyphenyl)-9-(4-methylfuran-2-yl)-3,4,8-trimethylnona-4,7-dien-1-one|ferulaeone D
(4E,7E)-1-(2,4-dihydroxyphenyl)-9-(4-methylfuran-2-yl)-3,4,8-trimethylnona-4,7-dien-1-one|ferulaeone D
1-hydroxy-6,6,9-trimethyl-3-pentyl-6H-benzo[c]chromene-2-carboxylic acid methyl ester|Cannabinolinsaeure-methylester|Cannabinolsaeure-methylester
1-hydroxy-6,6,9-trimethyl-3-pentyl-6H-benzo[c]chromene-2-carboxylic acid methyl ester|Cannabinolinsaeure-methylester|Cannabinolsaeure-methylester
17-phenyl trinor Prostaglandin A2
9-oxo-15S-hydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,10,13E-trien-1-oic acid
(S,E)-2-(4,8-dimethylnona-3,7-dien-1-yl)-5-hydroxy-2-methyl-2H-chromene-7,8-dicarbaldehyde
(S,E)-2-(4,8-dimethylnona-3,7-dien-1-yl)-5-hydroxy-2-methyl-2H-chromene-7,8-dicarbaldehyde
Gly Pro Pro Val
(2S)-2-{[(2S)-1-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid
Gly Pro Val Pro
(2S)-1-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid
Gly Val Pro Pro
(2S)-1-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid
Pro Gly Pro Val
(2S)-3-methyl-2-{[(2S)-1-{2-[(2S)-pyrrolidin-2-ylformamido]acetyl}pyrrolidin-2-yl]formamido}butanoic acid
Pro Gly Val Pro
(2S)-1-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanoyl]pyrrolidine-2-carboxylic acid
Pro Pro Gly Val
(2S)-3-methyl-2-(2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}acetamido)butanoic acid
Pro Pro Val Gly
2-[(2S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]acetic acid
Pro Val Gly Pro
(2S)-1-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetyl}pyrrolidine-2-carboxylic acid
Pro Val Pro Gly
2-{[(2S)-1-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}acetic acid
Val Gly Pro Pro
(2S)-1-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid
Val Pro Gly Pro
(2S)-1-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetyl)pyrrolidine-2-carboxylic acid
Val Pro Pro Gly
2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}acetic acid
trans,trans-3,4,5-trifluorophenyl 4-ethylbicyclohexyl-4-carboxylate
trans,trans-3,4,5-trifluorophenyl 4-ethylbicyclohexyl-4-carboxylate
2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride
2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium chloride
BMS-690514
(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
tert-Butyl 5-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
tert-Butyl 5-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
tert-Butyl 6-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
tert-Butyl 6-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
4,4,4,4,7,7-hexamethyl-2,2-spirobi[3H-chromene]-6,6-diol
4,4,4,4,7,7-hexamethyl-2,2-spirobi[3H-chromene]-6,6-diol
2-[(1E,3E,5E)-6-(DIMETHYLAMINO)HEXA-1,3,5-TRIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM TETRAFLUOROBORATE
2-[(1E,3E,5E)-6-(DIMETHYLAMINO)HEXA-1,3,5-TRIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM TETRAFLUOROBORATE
4,4-Dihydroxy-3,3,5,5-tetramethyldiphenylmethane diglycidyl ether
4,4-Dihydroxy-3,3,5,5-tetramethyldiphenylmethane diglycidyl ether
4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, hydrogen sulfate, sodium salt
4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, hydrogen sulfate, sodium salt
2-Hydroxy-2-methyl-1-phenyl-1-propanone mixt. with (1-hydroxycyclohexyl)phenylmethanone
2-Hydroxy-2-methyl-1-phenyl-1-propanone mixt. with (1-hydroxycyclohexyl)phenylmethanone
4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol
4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol
(2-((3,5-Di-t-butyl-4-hydroxyphenyl)thio)-1-methylpropoxy)acetic acid
2-({3-[(3,5-di-tert-butyl-4-hydroxyphenyl)sulphanyl]butan-2-yl}oxy)acetic acid
[3-carboxy-2-[(6E,8E,10E)-11-carboxyundeca-6,8,10-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(6E,8E,10E)-11-carboxyundeca-6,8,10-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,7E,10E)-11-carboxyundeca-4,7,10-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,7E,10E)-11-carboxyundeca-4,7,10-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2E,6E,8E)-11-carboxyundeca-2,6,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2E,6E,8E)-11-carboxyundeca-2,6,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(5E,7E,9E)-11-carboxyundeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(5E,7E,9E)-11-carboxyundeca-5,7,9-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,6E,8E)-11-carboxyundeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(4E,6E,8E)-11-carboxyundeca-4,6,8-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(3E,6E,9E)-11-carboxyundeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(3E,6E,9E)-11-carboxyundeca-3,6,9-trienoyl]oxypropyl]-trimethylazanium
Pro-Val-Gly-Pro
Pro-Val-Gly-Pro
A tetrapeptide composed of L-proline, L-valine, glycine, and L-proline joined by peptide linkages.
4-[(E)-{2-[2,6-di(pyrrolidin-1-yl)pyrimidin-4-yl]hydrazinylidene}methyl]benzene-1,2-diol
4-[(E)-{2-[2,6-di(pyrrolidin-1-yl)pyrimidin-4-yl]hydrazinylidene}methyl]benzene-1,2-diol
(Z)-N-[4-(9H-Fluoren-9-yl)piperazin-1-yl]-1-pyridin-4-ylethanimine
(Z)-N-[4-(9H-Fluoren-9-yl)piperazin-1-yl]-1-pyridin-4-ylethanimine
(9R,17R)-9-fluoro-6,11,16,17-tetrahydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(9R,17R)-9-fluoro-6,11,16,17-tetrahydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
(1S,5R)-7-[4-[(Z)-2-phenylethenyl]phenyl]-6-(pyrimidin-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane
(1S,5R)-7-[4-[(Z)-2-phenylethenyl]phenyl]-6-(pyrimidin-5-ylmethyl)-3,6-diazabicyclo[3.1.1]heptane
6-[4-(1-cyclohexyl-2H-tetrazol-1-ium-5-yl)butoxy]-1H-quinolin-2-one
6-[4-(1-cyclohexyl-2H-tetrazol-1-ium-5-yl)butoxy]-1H-quinolin-2-one
(2-Acetamido-3-hydroxyoctyl) 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetamido-3-hydroxyoctyl) 2-(trimethylazaniumyl)ethyl phosphate
(2s)-2,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-1-benzopyran
(2s)-2,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-1-benzopyran
1,11-bis(furan-3-yl)-4,8-dimethylundeca-3,6,8-trien-2-yl acetate
1,11-bis(furan-3-yl)-4,8-dimethylundeca-3,6,8-trien-2-yl acetate
(1r,2r,3s,5r,6r,7s,10s,11r,15r)-6-hydroxy-15-isopropyl-13-methyl-5-phenyl-4,8-dioxatetracyclo[9.2.2.0²,¹⁰.0³,⁷]pentadec-12-en-9-one
(1r,2r,3s,5r,6r,7s,10s,11r,15r)-6-hydroxy-15-isopropyl-13-methyl-5-phenyl-4,8-dioxatetracyclo[9.2.2.0²,¹⁰.0³,⁷]pentadec-12-en-9-one
4,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran
4,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran
(2e,4e,6e,16e)-18-methoxy-4,8,11,15-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoic acid
(2e,4e,6e,16e)-18-methoxy-4,8,11,15-tetramethyl-18-oxooctadeca-2,4,6,8,10,12,14,16-octaenoic acid
(2s,3e,6e,8e)-1,11-bis(furan-3-yl)-4,8-dimethylundeca-3,6,8-trien-2-yl acetate
(2s,3e,6e,8e)-1,11-bis(furan-3-yl)-4,8-dimethylundeca-3,6,8-trien-2-yl acetate
6-hydroxy-15-isopropyl-13-methyl-5-phenyl-4,8-dioxatetracyclo[9.2.2.0²,¹⁰.0³,⁷]pentadec-12-en-9-one
6-hydroxy-15-isopropyl-13-methyl-5-phenyl-4,8-dioxatetracyclo[9.2.2.0²,¹⁰.0³,⁷]pentadec-12-en-9-one
(1r,4r,5s,6r,16s)-6,16-dihydroxy-4-isopropyl-5,6,13-trimethyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-13-ium
(1r,4r,5s,6r,16s)-6,16-dihydroxy-4-isopropyl-5,6,13-trimethyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-13-ium
(2s,4s)-4,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran
(2s,4s)-4,5,7-trimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran
(1r,4r,5s,6r,13r,16s)-6,16-dihydroxy-4-isopropyl-5,6,13-trimethyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-13-ium
(1r,4r,5s,6r,13r,16s)-6,16-dihydroxy-4-isopropyl-5,6,13-trimethyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-13-ium
(1s,4s,4as,8as)-3-formyl-4-hydroxy-4a,8,8-trimethyl-1,4,5,6,7,8a-hexahydronaphthalen-1-yl (2e)-3-phenylprop-2-enoate
(1s,4s,4as,8as)-3-formyl-4-hydroxy-4a,8,8-trimethyl-1,4,5,6,7,8a-hexahydronaphthalen-1-yl (2e)-3-phenylprop-2-enoate
3-formyl-4-hydroxy-4a,8,8-trimethyl-1,4,5,6,7,8a-hexahydronaphthalen-1-yl 3-phenylprop-2-enoate
3-formyl-4-hydroxy-4a,8,8-trimethyl-1,4,5,6,7,8a-hexahydronaphthalen-1-yl 3-phenylprop-2-enoate
4-[(3e,5e,7e)-8,10-dimethyl-2-methylideneundeca-3,5,7-trien-1-yl]-2-methylbenzene-1,3-dicarboxylic acid
4-[(3e,5e,7e)-8,10-dimethyl-2-methylideneundeca-3,5,7-trien-1-yl]-2-methylbenzene-1,3-dicarboxylic acid
